MD247B1 - Process for the crystalline hydrated form of the sodium salt of 3-acetoxymethyl-7- [2- (2-amino-4-thiazolyl) -2-methoxyiminoacetamido] -cef-3-em-4-carbonic acid sodium salt - Google Patents

Process for the crystalline hydrated form of the sodium salt of 3-acetoxymethyl-7- [2- (2-amino-4-thiazolyl) -2-methoxyiminoacetamido] -cef-3-em-4-carbonic acid sodium salt

Info

Publication number
MD247B1
MD247B1 MD940275A MD940275A MD247B1 MD 247 B1 MD247 B1 MD 247B1 MD 940275 A MD940275 A MD 940275A MD 940275 A MD940275 A MD 940275A MD 247 B1 MD247 B1 MD 247B1
Authority
MD
Moldova
Prior art keywords
sodium salt
methoxyiminoacetamido
cef
acetoxymethyl
thiazolyl
Prior art date
Application number
MD940275A
Other languages
Romanian (ro)
Other versions
MD247C2 (en
Inventor
Gaston Amiard
Dieter Bormann
Walter Duerckheimer
Jean Jolly
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9194564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MD247(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of MD247B1 publication Critical patent/MD247B1/en
Publication of MD247C2 publication Critical patent/MD247C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MD94-0275A 1977-08-17 1994-09-08 Method of preparation of hydrated crystalline form of natrium salt of 3-acetaoxymethyl-7-(2-(2-amino-4 thiazolyl)-2-methoxyiminoacetamylou-cef-3em-4-carbonic acid, sin-isomer MD247C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7725142A FR2400519A1 (en) 1977-08-17 1977-08-17 CRYSTALLINE FORM OF SODIUM SALT OF AN OXIMIN DERIVATIVE OF 7-AMINO-THIAZOLYL ACETAMIDO CEPHALOSPORANIC, ITS PREPARATION PROCESS AND ITS APPLICATION AS A MEDICINAL PRODUCT
SU782645701A SU799666A3 (en) 1977-08-17 1978-08-09 Method of preparing hydrated crystalline form of sodium salt of 3-acetoxymethyl-7-/2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido/ceph-3-em-4-carboxyl acid, sin-isomer

Publications (2)

Publication Number Publication Date
MD247B1 true MD247B1 (en) 1995-07-31
MD247C2 MD247C2 (en) 1995-12-31

Family

ID=9194564

Family Applications (2)

Application Number Title Priority Date Filing Date
MD94-0267A MD225C2 (en) 1977-08-17 1994-09-08 Method of hydrated crystalline form of natrium salt 3-acetoxymethyl-7o2-(2-amino-4-triazolyl)-2-methoxyiminoacetamidou cef-3-em-4-carbonic acid, sin isomer preparation
MD94-0275A MD247C2 (en) 1977-08-17 1994-09-08 Method of preparation of hydrated crystalline form of natrium salt of 3-acetaoxymethyl-7-(2-(2-amino-4 thiazolyl)-2-methoxyiminoacetamylou-cef-3em-4-carbonic acid, sin-isomer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MD94-0267A MD225C2 (en) 1977-08-17 1994-09-08 Method of hydrated crystalline form of natrium salt 3-acetoxymethyl-7o2-(2-amino-4-triazolyl)-2-methoxyiminoacetamidou cef-3-em-4-carbonic acid, sin isomer preparation

Country Status (34)

Country Link
US (1) US4224371A (en)
EP (1) EP0001024B1 (en)
JP (1) JPS5441890A (en)
AT (2) AT366049B (en)
AU (1) AU520898B2 (en)
BG (2) BG33888A3 (en)
CA (1) CA1121343A (en)
CS (2) CS207646B2 (en)
DD (1) DD137588A5 (en)
DE (1) DE2860358D1 (en)
DK (2) DK152213C (en)
EG (1) EG13520A (en)
ES (1) ES472381A1 (en)
FI (1) FI65433C (en)
FR (1) FR2400519A1 (en)
GE (2) GEP19960475B (en)
GR (1) GR73661B (en)
HR (1) HRP931395B1 (en)
HU (1) HU181497B (en)
IE (1) IE47230B1 (en)
IL (1) IL55186A (en)
IT (1) IT1107961B (en)
MD (2) MD225C2 (en)
MX (2) MX155976A (en)
NO (1) NO156168C (en)
NZ (1) NZ188163A (en)
OA (1) OA06016A (en)
PL (1) PL126619B1 (en)
PT (1) PT68431A (en)
RO (1) RO79999A (en)
SI (1) SI7811917A8 (en)
SU (2) SU799666A3 (en)
YU (1) YU42166B (en)
ZA (1) ZA784187B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120886A (en) * 1983-12-02 1985-06-28 Takeda Chem Ind Ltd Crystal of cephemcarboxylic acid sodium salt
DE3485860T2 (en) * 1983-12-29 1993-01-14 Mochida Pharm Co Ltd CEPHALOSPORINE COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS.
JPS60142987A (en) * 1983-12-29 1985-07-29 Mochida Pharmaceut Co Ltd Cephalosporin derivative
US4840945A (en) * 1985-04-01 1989-06-20 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
ATE138664T1 (en) * 1985-08-12 1996-06-15 Upjohn Co CONVERSION OF CEPHALOSPORIN HYDROHALIDE SALT TO AN ALKALINE METAL SALT
US4880798A (en) * 1986-11-25 1989-11-14 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
JPS63132893A (en) * 1986-11-25 1988-06-04 Mochida Pharmaceut Co Ltd Novel cephalosporin derivative, production thereof and antibacterial agent containing said derivative as active ingredient
RU2021274C1 (en) 1991-05-17 1994-10-15 Польска Акадэмия Наук Институт Хэмии Органичнэй Process for preparing aminothiazolyl cephalosporin derivatives
US5318781A (en) * 1993-04-06 1994-06-07 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics
US5574154A (en) * 1994-09-29 1996-11-12 Alnejma Bulk Pharmaceutical Co. A.B.P.C. Process for the preparation of cephalosporanic compounds
GB9423459D0 (en) * 1994-11-21 1995-01-11 Biochemie Gmbh Silylation process
AT402928B (en) * 1994-12-23 1997-09-25 Biochemie Gmbh NEW METHOD FOR PRODUCING CEFOTAXIM
AU690482B2 (en) * 1996-03-18 1998-04-23 Ranbaxy Laboratories Limited Process for producing cephalosporin antibiotics
GB9717629D0 (en) * 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents
WO2001092254A1 (en) * 2000-05-30 2001-12-06 Fujisawa Pharmaceutical Co., Ltd. Method for replacing organic solvents contained in clathrate crystals
WO2004063203A1 (en) * 2003-01-10 2004-07-29 Orchid Chemicals & Pharmaceuticals Ltd Process for the preparation of cefotaxime sodium
CN100361995C (en) * 2004-10-27 2008-01-16 山东瑞阳制药有限公司 One-step preparation process of aseptic cefotaxime sodium for injection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3970651A (en) * 1974-01-07 1976-07-20 Bristol-Myers Company Crystalline cephalosporin derivative
US3985747A (en) * 1974-05-24 1976-10-12 Bristol-Myers Company Crystalline sesquihydrate of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
DK154939C (en) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd METHOD OF ANALOGUE FOR THE PREPARATION OF THIAZOLYLACETAMIDO-CEPHEM COMPOUNDS OR PHARMACEUTICAL ACCEPTABLE SALTS OR ESTERS THEREOF
US4006138A (en) * 1975-04-11 1977-02-01 Eli Lilly And Company Crystalline form of sodium O-formylcefamandole
DE2760123C2 (en) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporanic acids, their preparation and pharmaceutical compositions containing them
SE440655B (en) * 1976-01-23 1985-08-12 Roussel Uclaf SET TO MAKE NEW OXIME DERIVATIVES OF 7-AMINO-THIAZOLYL-ACETAMIDO-CEPHALOSPORANIC ACID

Also Published As

Publication number Publication date
JPS6145626B2 (en) 1986-10-08
BG33888A3 (en) 1983-05-16
NO156168C (en) 1987-08-19
FR2400519A1 (en) 1979-03-16
MX5448E (en) 1983-08-09
DE2860358D1 (en) 1981-03-12
FI65433C (en) 1984-05-10
DK159786D0 (en) 1986-04-09
ES472381A1 (en) 1979-03-16
EP0001024A1 (en) 1979-03-07
DD137588A5 (en) 1979-09-12
GEP19960475B (en) 1996-07-22
DK163514C (en) 1992-07-27
JPS5441890A (en) 1979-04-03
OA06016A (en) 1981-06-30
NO156168B (en) 1987-04-27
IL55186A0 (en) 1978-09-29
YU42166B (en) 1988-06-30
AT366049B (en) 1982-03-10
IE47230B1 (en) 1984-01-25
IL55186A (en) 1981-07-31
NZ188163A (en) 1981-10-19
ATA563578A (en) 1981-07-15
SI7811917A8 (en) 1997-12-31
ATA52280A (en) 1981-07-15
BG33887A3 (en) 1983-05-16
PT68431A (en) 1978-09-01
SU852175A3 (en) 1981-07-30
AU3896578A (en) 1980-02-21
YU191778A (en) 1983-02-28
GEP19960476B (en) 1996-07-22
DK361078A (en) 1979-02-18
MD225C2 (en) 1995-12-31
AT366050B (en) 1982-03-10
DK163514B (en) 1992-03-09
EP0001024B1 (en) 1981-01-21
IT1107961B (en) 1985-12-02
EG13520A (en) 1982-03-31
ZA784187B (en) 1979-09-26
FI782494A (en) 1979-02-18
DK152213C (en) 1988-07-11
IE781669L (en) 1979-02-17
GR73661B (en) 1984-03-28
DK159786A (en) 1986-04-09
CS207646B2 (en) 1981-08-31
CS207647B2 (en) 1981-08-31
RO79999A (en) 1982-10-11
CA1121343A (en) 1982-04-06
HRP931395B1 (en) 1996-04-30
FI65433B (en) 1984-01-31
MD225B1 (en) 1995-06-30
MX155976A (en) 1988-06-06
US4224371A (en) 1980-09-23
AU520898B2 (en) 1982-03-04
PL209080A1 (en) 1979-06-04
PL126619B1 (en) 1983-08-31
SU799666A3 (en) 1981-01-23
FR2400519B1 (en) 1980-05-16
IT7850648A0 (en) 1978-08-08
HU181497B (en) 1983-07-28
DK152213B (en) 1988-02-08
MD247C2 (en) 1995-12-31
NO782782L (en) 1979-02-20

Similar Documents

Publication Publication Date Title
MD247B1 (en) Process for the crystalline hydrated form of the sodium salt of 3-acetoxymethyl-7- [2- (2-amino-4-thiazolyl) -2-methoxyiminoacetamido] -cef-3-em-4-carbonic acid sodium salt
RO75757A (en) PROCESS FOR THE PURIFICATION OF VINYLAROMATIC COMPOUNDS
RO80193A (en) PROCESS FOR THE MANUFACTURE OF SODIUM SILICATE
FR2549836B1 (en) PROCESS FOR THE PREPARATION OF CEFUROXIME SODIUM SALT
GB2004552B (en) Process for the production of heterocyclic compounds
KR840004685A (en) Method for the production of thiazole derivatives
PT67713B (en) PROCESS FOR THE PRODUCTION OF SODIUM CARBONATE MONOHYDRATE CRYSTALS
IT1109398B (en) PROCEDURE FOR PREPARING CEPHALOSPORIN COMPOUNDS
SE438337B (en) PROCEDURE FOR PREPARING 2- (METHYL) -7-SUBSTITUTED 3-CEFEM-4-CARBOXYLIC ACID COMPOUNDS
RO69709A (en) PROCESS FOR THE PREPARATION OF A METHANOLIC CRYSTALLINE FORM OF SODIUM 7- (D-2-HYDROXY-2-PHENYLACETOMIDE) -3- (1-METHYL-1H-TETRAZOLE-5-ILTHIOMETHYL) -3-CEPHEM-4-CARBOXYLATE
GB2036746B (en) Crystalline salt of a cephalosporin derivative
LU81347A1 (en) PROCESS FOR THE PREPARATION OF 7-D-MANDELAMIDO-3- (1-METHYL-1H-TETRAZOL-5-YLTHIOMETHYL) -3-CEPHEM-4-SODIUM CARBOXYLATE CRYSTALLINE METHANOLATE
PT65932B (en) Process for the preparation of a crystalline modification of a sodium salt
RO77896A (en) PROCESS FOR OBTAINING SODIUM CHLORIDE
GB1557771A (en) Process for the production of salts of poly-alphahydroxyacrylic acids
RO78325A (en) PROCESS FOR THE PREPARATION OF HETEROCYCLIC COMPOUNDS
JPS52139019A (en) Process for manufacturing alkali salt of alkyl sulfonic acid
RO70828A (en) PROCESS FOR THE PREPARATION OF 2- (DIMETHYLCARBAMOILIMINO) -BENZTHIAZOLIN-3-IDE SALTS
PT68820A (en) PROCESS FOR THE PREPARATION OF THIAZOLE DERIVATIVES
RO75583A2 (en) PROCESS FOR THE MANUFACTURE OF SODIUM CARBONATE
RO85730A2 (en) PROCESS FOR OBTAINING SALT OF ALPHA-NAFTILACETIC ACID
RO70365A3 (en) PROCESS FOR PREPARATION OF SODIUM FEROACIONS
EG12898A (en) A process for the production of basically substituted alkyl theophilline derivatives
RO70040A2 (en) PROCESS FOR OBTAINING ADVANCED POTASSIUM SODIUM ASCORBATE
MD228B1 (en) Process for obtaining 7- [2- (2-aminothiazolyl-4) -2-oxyiminoacetamido] -3-acetoxymethyl-3-cefem-4-carbonic acid or its alkali metal salts

Legal Events

Date Code Title Description
1K4A Payment of annual fees